Trulieve Q3 revenue $301M (+34% YoY); net loss $115M with $93M impairments; adj. EBITDA $99M

Trulieve Cannabis Corp.

2022-Q3 EPS reported -$0.68 revenue$937,612,000

Revenue $301M (+34% YoY); 94% retail; GAAP gross margin 56%, gross profit $168M.
Net loss $115M includes $93M asset impairments from exiting CA dispensaries, redundant FL cultivation, and NV wholesale.
Adjusted net income $4M (excl. $26M transaction/integration charges & $93M impairments); adj. EBITDA $99M (33% margin).
Cash $114M; capex $38M; expects significant decline in supply chain investments in 2023.
Opened 11 new dispensaries in AZ, FL, WV; first Trulieve-branded store in Phoenix; began cultivation in Georgia.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Trulieve Cannabis Corp. reported financial results for three and nine months ended September 30, 2022.

Period: three and nine months ended September 30, 2022
Result: reported results

Exact text from the filing

On November 9, 2022, Trulieve Cannabis Corp. (the “Company”) announced via press release its results for the three and nine months ended September 30, 2022. A copy of the Company’s press release is hereby furnished to the Commission and incorporated herein by reference as Exhibit 99.1.

View on SEC.gov

13 earnings releases filed in the last 30 days. Browse all earnings releases →

Trulieve Cannabis Corp. filing history →

Source: SEC EDGAR

accession 0001193125-22-281243

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.